Free Trial

Venus Concept (VERO) Competitors

Venus Concept logo
$2.39 -0.04 (-1.65%)
Closing price 04:00 PM Eastern
Extended Trading
$2.33 -0.06 (-2.72%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VERO vs. PETV, BSGM, ICU, PAVM, BTCY, ALUR, SSKN, CODX, POAI, and NURO

Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include PetVivo (PETV), BioSig Technologies (BSGM), SeaStar Medical (ICU), PAVmed (PAVM), Biotricity (BTCY), Allurion Technologies (ALUR), STRATA Skin Sciences (SSKN), Co-Diagnostics (CODX), Predictive Oncology (POAI), and NeuroMetrix (NURO). These companies are all part of the "medical equipment" industry.

Venus Concept vs.

PetVivo (NASDAQ:PETV) and Venus Concept (NASDAQ:VERO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation, risk and community ranking.

PetVivo has a beta of 1.85, indicating that its stock price is 85% more volatile than the S&P 500. Comparatively, Venus Concept has a beta of 0.25, indicating that its stock price is 75% less volatile than the S&P 500.

Venus Concept has a net margin of -74.62% compared to PetVivo's net margin of -902.82%. Venus Concept's return on equity of 0.00% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
PetVivo-902.82% -4,813.07% -281.78%
Venus Concept -74.62%N/A -47.46%

PetVivo has higher earnings, but lower revenue than Venus Concept. PetVivo is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PetVivo$1.05M13.89-$10.95M-$0.45-1.33
Venus Concept$64.83M0.05-$37.25M-$77.35-0.03

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 87.4% of Venus Concept shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 49.0% of Venus Concept shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Venus Concept received 34 more outperform votes than PetVivo when rated by MarketBeat users.

CompanyUnderperformOutperform
PetVivoN/AN/A
Venus ConceptOutperform Votes
34
65.38%
Underperform Votes
18
34.62%

In the previous week, Venus Concept had 1 more articles in the media than PetVivo. MarketBeat recorded 2 mentions for Venus Concept and 1 mentions for PetVivo. Venus Concept's average media sentiment score of 0.43 beat PetVivo's score of 0.00 indicating that Venus Concept is being referred to more favorably in the news media.

Company Overall Sentiment
PetVivo Neutral
Venus Concept Neutral

Summary

Venus Concept beats PetVivo on 10 of the 14 factors compared between the two stocks.

Get Venus Concept News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERO vs. The Competition

MetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$3.36M$4.34B$5.50B$7.96B
Dividend YieldN/A39.94%5.11%4.23%
P/E Ratio-0.2930.6722.6318.55
Price / Sales0.0555.17397.30103.38
Price / CashN/A51.0838.1834.62
Price / Book-0.976.056.704.25
Net Income-$37.25M$68.71M$3.23B$248.27M
7 Day Performance-9.92%-0.13%1.36%1.28%
1 Month Performance-9.92%-2.30%3.85%3.75%
1 Year Performance-67.82%22.45%15.87%5.31%

Venus Concept Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERO
Venus Concept
0.9021 of 5 stars
$2.39
-1.6%
N/A-66.5%$3.40M$64.83M-0.30410Gap Down
PETV
PetVivo
N/A$0.56
+2.8%
N/A-24.1%$13.56M$1.05M-1.2420Gap Down
BSGM
BioSig Technologies
2.2665 of 5 stars
$1.04
+13.0%
$2.50
+140.4%
-38.0%$12.49M$40,000.000.0050Positive News
High Trading Volume
ICU
SeaStar Medical
0.6426 of 5 stars
$1.27
+0.8%
N/A-89.3%$12.45M$135,000.00-0.112Short Interest ↓
News Coverage
PAVM
PAVmed
4.4114 of 5 stars
$0.72
-5.3%
$19.50
+2,608.3%
-63.8%$12.31M$3.00M-0.1790Short Interest ↓
Gap Up
BTCY
Biotricity
N/A$0.46
+0.0%
N/A-66.4%$11.46M$12.06M-0.4340Gap Up
ALUR
Allurion Technologies
3.426 of 5 stars
$2.38
-0.8%
$22.83
+859.0%
-95.2%$11.42M$32.11M-0.20501Positive News
Gap Down
SSKN
STRATA Skin Sciences
3.5167 of 5 stars
$2.61
-0.2%
$6.00
+129.5%
-40.9%$10.90M$33.56M-0.98120Short Interest ↓
Gap Up
CODX
Co-Diagnostics
4.3206 of 5 stars
$0.37
+6.0%
$5.50
+1,382.1%
-69.7%$10.43M$3.92M-0.27100Upcoming Earnings
Analyst Forecast
News Coverage
Gap Up
POAI
Predictive Oncology
2.8054 of 5 stars
$1.06
flat
$3.00
+183.0%
-23.1%$9.47M$1.62M-0.3530
NURO
NeuroMetrix
0.4081 of 5 stars
$4.39
+1.0%
N/A-0.2%$9.03M$3.03M-0.9620Analyst Forecast
News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:VERO) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners